Company Filing History:
Years Active: 2013-2025
Title: Leonard D. Shultz: Innovator in Immunotherapy Research
Introduction
Leonard D. Shultz is a prominent inventor based in Bar Harbor, Maine, known for his significant contributions to the field of immunotherapy. With a total of nine patents to his name, he has made remarkable strides in understanding the interactions between the human immune system and cancer.
Latest Patents
Among his latest patents, Shultz has developed methods and models for assessing the efficacy of immunotherapies. One notable patent describes a method for identifying the anti-tumor activity of a test substance, utilizing a genetically-modified, immunodeficient mouse. This innovative model allows for in vivo investigations of the interactions between the human immune system and human cancer. Another significant patent involves transgenic mouse models that support innate immune function. This patent details a NOD.Cg-PrkdcIl2rg/SzJ (NOD scid gamma or NSG™) mouse, which includes a nucleic acid encoding human FLT3L and an inactivated mouse Flt3 allele, along with methods for producing and using this mouse.
Career Highlights
Shultz has had a distinguished career, working with esteemed organizations such as The Jackson Laboratory and the University of Massachusetts. His work has been pivotal in advancing the understanding of immunotherapy and its applications in cancer treatment.
Collaborations
Throughout his career, Shultz has collaborated with notable colleagues, including Dale L. Greiner and Michael A. Brehm. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Leonard D. Shultz's contributions to immunotherapy research through his patents and collaborations have significantly impacted the scientific community. His innovative approaches continue to pave the way for advancements in cancer treatment and immunological studies.